Orlando Dermatology Aesthetic and Clinical (ODAC) Dermatology, Aesthetic & Surgical Conference 2020

Orlando Dermatology Aesthetic and Clinical (ODAC) Dermatology, Aesthetic & Surgical Conference is organized by Orlando Dermatology Aesthetic and Clinical (ODAC) and will be held from Jan 17 - 20, 2020 at JW Marriott Orlando, Grande Lakes, Orlando, Florida, United States of America.

Accreditation:
Education Credits:
Jan 17: 10.75 | Jan 18: 7.75 | Jan 19: 8.5 | Jan 20: 4.0
Conference Total: 31.0

Category 1:
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 31 AMA PRA Category 1 Credit(s)™.

Nurses CE:
Creighton University Health Sciences Continuing Education designates this activity for 31 contact hour(s) for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
Upon completion of the ODAC, participants should be able to:
• Define intrinsic and extrinsic factors of the normal aging process in patients with all skin types
• Select and formulate the appropriate aesthetic treatment plan using neurotoxins, dermal fillers, laser and light-based energy therapy technologies and cosmeceutical products in patients of all skin types who seek improvement in facial and skin appearance
• Compare patient selection, choice of injectable products and technique required to avoid potential complications and achieve optimal patient outcomes
• Express current understanding of the pathophysiology of acne as it relates to effective diagnosis and treatment
• Discuss current theories on the pathogenesis of rosacea including the identification of genetic factors and gene loci that predispose affected patients to a rosacea phenotype
• Analyze evidence-based data on acne treatment options in order to improve treatment outcomes and improve patient adherence to therapy
• Examine emerging clinical and therapeutic science insights into the pathogenesis and effective management of atopic dermatitis including new modalities recently introduced into clinical practice
• Discuss the role of the innate and adaptive immune system function in normal skin and how changes in the immune system may contribute to inflammatory disease
• Identify the psoriasis patient population that would benefit most from topical and systemic therapies including biologic response modifiers
• Assess evidence-based data on the relationship between psoriasis comorbidities and therapeutic selection
• Indicate the types of superficial fungal infection presenting in the dermatology setting including tinea pedis, tinea cruris and tinea corporis and onychomycosis and formulate effective treatment strategies
• Summarize current and emerging therapies that hold promise for the effective treatment of skin cancers including actinic keratosis, basal cell carcinoma and melanoma
• Identify the impact of various cutaneous disorders affecting the delivery of quality dermatologic care including seborrheic keratosis and other non-cancerous growths, chronic urticaria, hyperhidrosis among others
• Recognize the impact of race, ethnicity and cultural practices on the treatment of cutaneous diseases in persons with diverse skin types
• Differentiate clinical signs of disorders of pigmentation including melasma and vitiligo and outline treatment courses effective for patients of all skin types